Phosphorylation deficient inducible cAMP early repressor (ICER) modulates tumorigenesis and survival in a transgenic zebrafish ( Danio rerio ) model of melanoma
Biology Open · 2025
DOI: 10.1242/bio.061904 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology Open, 2025. Verfasst von Justin Wheelan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Montclair State University, Montclair, NJ 07043,USA. Hauptthemen laut MEDLINE: Melanoma, Cyclic AMP Response Element Modulator, Carcinogenesis, Zebrafish Proteins. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, College of Science and Mathematics and Biology Department, Montclair State University, Montclair New Jersey, Foundation for the National Institutes of Health.
Abstract (Originalsprache)
Melanoma, the most lethal form of skin cancer, is commonly associated with mutations in the BRAF gene, particularly BRAFV600E, which drives tumor proliferation via the ERK1/2 signaling cascade. While BRAF inhibitors initially demonstrate efficacy, therapeutic resistance remains a significant challenge. Emerging evidence implicates the cAMP signaling pathway, particularly the cAMP response element-binding protein (CREB) and its repressor, inducible cAMP early repressor (ICER), in melanoma progression and drug resistance. ICER, a transcriptional repressor regulated via Ras/MAPK-mediated phosphorylation and ubiquitination, is degraded in melanoma, undermining its tumor-suppressive role. In a brafV600E; p53 (loss of function) transgenic zebrafish (Danio rerio) model, we investigated the role of a ubiquitin-resistant ICER mutant (S35-41A-ICER) in tumor progression. Transgenic fish expressing S35-41A-ICER exhibited extended survival and reduced tumor invasiveness compared to wild-type ICER. RNA sequencing revealed dysregulation of CREB/CREM targets and compensatory pathways, including Rap1 and PI3K/AKT signaling, as well as candidate gene targets of ICER regulation, including the protein kinase A catalytic subunit prkacaa. Our findings suggest that a ubiquitin resistant ICER mitigates melanoma progression and represses oncogenic pathways in a brafV600E melanoma context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Montclair State University, Montclair, NJ 07043,USA.
ORCID-Profile: Justin Wheelan
Förderung
- NIGMS NIH HHS
- College of Science and Mathematics and Biology Department, Montclair State University, Montclair New Jersey
- Foundation for the National Institutes of Health
Zitieren
APA
Wheelan, J., Spigelman, M., Cirinelli, A., Reilly, J., & Molina, C. A. (2025). Phosphorylation deficient inducible cAMP early repressor (ICER) modulates tumorigenesis and survival in a transgenic zebrafish ( Danio rerio ) model of melanoma. Biology Open. https://doi.org/10.1242/bio.061904
Vancouver
Wheelan J, Spigelman M, Cirinelli A, Reilly J, Molina CA. Phosphorylation deficient inducible cAMP early repressor (ICER) modulates tumorigenesis and survival in a transgenic zebrafish ( Danio rerio ) model of melanoma. Biology Open. 2025. doi:10.1242/bio.061904
BibTeX
@article{Wheelan2025,
author = {Wheelan, Justin and Spigelman, Melissa and Cirinelli, Angelo and Reilly, James and Molina, Carlos A},
title = {Phosphorylation deficient inducible cAMP early repressor (ICER) modulates tumorigenesis and survival in a transgenic zebrafish ( Danio rerio ) model of melanoma},
journal = {Biology Open},
year = {2025},
doi = {10.1242/bio.061904}
}
EUVIMED